TwinCaps®, a marketed disposable inhaler

The TwinCaps®, Hovione’s single use, two-dose, pre-filled, disposable inhaler was developed in 2006 for Daiichi-Sankyo and Biota and it has been a notable market success story. 

TwinCaps was specifically developed as a single-use disposable DPI for acute use to deliver a long-acting neuraminidase inhibitor for treating influenza. The Inavir® (link to Inavir), Daiichi-Sankyo’s influenza anti-viral drug product, entered the market in 2010 in Japan, turning TwinCaps into the world’s first market approved disposable device. The product is the current category market leader, outselling all competitors. 

TwinCaps is indicated for applications where a pre-filled, disposable, low-cost device is needed, with extreme ease of use. 

Applications include:

  • Anti-virals
  • Antibiotics for lung infection and pulmonary hypertension drugs 
  • Vaccines
  • Pain management
  • Military and rescue treatments
 

TwinCaps is available for clinical trial supply and for licensing.

return